CAV2 p.Phe91Ser
c.272T>C · VCV4648671
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4139 | ambiguous |
|---|---|---|
| REVEL | 0.737 | pathogenic-leaning |
| SaProt | LLR -9.84 | tolerated |
| ⇒ REVEL calls this damaging; SaProt does not; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.9 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 1.10 | unconstrained · MANE · 6,336 bp · p 0.16 · regional, not allelic |
| Overall | ||
| CADD | 26.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CAV2
- Protein
- p.Phe91Ser
- Coding
- c.272T>C
- MANE Select
- NM_001233
- Type
- single nucleotide variant
- Location
- chr7:116500381 (GRCh38)
- Gene constraint
- LOEUF 0.938 · pLI 0.09 (gnomAD)
- Structure
- AlphaFold pLDDT 78.26
Similar variants
- CAV2 p.Ser147= Benign ★★ same type
- CAV2 p.Ala8Val Uncertain significance ★ ⚠ same type
- CAV2 p.Arg40Gln Uncertain significance ★ ⚠ same type
- CAV2 p.Asp17Ala Uncertain significance ★ ⚠ same type
- CAV2 p.Asp17Tyr Uncertain significance ★ ⚠ same type
- CAV2 p.Asp55Asn Uncertain significance ★ ⚠ same type
- CAV2 p.Cys151Tyr Uncertain significance ★ ⚠ same type
- CAV2 p.Gln158Lys Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cav2-p-phe91ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown